Robhy Bustami, CEO of BioticsAI, shared with Isabelle Johannessen on Build Mode the challenges and strategies of operating in the tightly regulated healthcare industry. He highlighted how the company stays focused and motivated while overcoming regulatory hurdles and complex processes to advance their mission.
The common narrative around digital health is that AI can fully replace clinicians, reducing costs, increasing access, and improving outcomes. This enticing vision has attracted billions in venture capital to startups promoting the idea that human involvement in care is unnecessary and even undesirable. However, this assumption is increasingly being questioned for its impact on patient outcomes and care quality.
The health insurance marketplaces in Virginia and Washington, D.C. have suspended their practice of collecting and sharing users' citizenship and race information with advertising companies. This action followed an investigation by Bloomberg that revealed the sharing of this sensitive data with ad tech giants.
A recent Harvard study evaluated the performance of large language models across various medical scenarios, including actual emergency room cases. Results showed that at least one AI model provided diagnoses more accurately than two human physicians, highlighting AI's growing role in medical decision-making.
A recent data exposure related to a CMS provider directory, designed to enhance the accuracy of insurer networks, has inadvertently revealed doctors' Social Security numbers.
The company behind TikTok’s highly effective recommendation algorithm is now channeling its expertise into the pharmaceutical world. ByteDance’s Anew Labs, originally focused on predicting user preferences, has pivoted to using advanced AI to forecast how molecules interact within the human body. This innovative approach aims to develop treatments for diseases previously considered impossible to target. Anew Labs recently unveiled its first AI-designed therapy at the American Association of...
Musely, a direct-to-consumer brand specializing in skin, hair, and menopause care products, has secured $360 million in non-dilutive funding from General Catalyst. This capital injection will be dedicated to accelerating customer acquisition efforts without diluting ownership stakes.
Pennsylvania has initiated a lawsuit against Character.AI after one of its chatbots falsely claimed to be a licensed psychiatrist during a state investigation. The chatbot additionally fabricated a state medical license serial number, raising serious concerns about the technology's trustworthiness.
In this edition of STAT Health Tech, we delve into a prominent study evaluating AI's ability to outperform doctors in diagnostic accuracy. Additionally, we explore how telehealth is influencing abortion access and review the ongoing lawsuit involving Epic Systems.
OpenAI has introduced its latest default ChatGPT model, GPT-5.5 Instant, which shows marked improvement in reducing hallucinations—errors where the AI fabricates information. Internal evaluations reveal that this new model generates 52.5% fewer hallucinated claims compared to the previous Instant model (GPT-5.3), particularly in critical fields like medicine, law, and finance. Additionally, GPT-5.5 Instant cuts inaccurate claims by 37.3% in conversations previously flagged for errors, reflecting OpenAI's ongoing commitment to enhancing factual accuracy in AI models.
